-
Most Popular
Search Results
240 results for ESRX
CVS Caremark Tops Q2 Profit, Misses on Revenue
CVS Caremark posted increased second-quarter earnings that topped Wall Street forecasts, but missed on revenue, and raised its earnings outlook for the year.
Tower Bancorp Leads S&P Gainers After Buyout Deal
Tower Bancorp tallied a nearly 23% gain in early trading today after Susquehanna Bancshares announced it would acquire the bank in a $343 million deal…
5 Booming Blue Chip Stocks to Buy Now
These five booming blue chip stocks will provide stability to your portfolio in the short-term and big profits in the months ahead.
Trade of the Day: GILD Stock Takes a Hit, Still a Great Buy
Gilead Sciences, Inc. sliced through its 200-day moving average before reversing up.
Rumor Could Give Traders Another Shot at a Top Biotech
Gilead Sciences’ (GILD) sell-off on an unconfirmed report may provide a good entry point.
Why I Went Long Coinstar
The recently announced deal with Starbucks is proof positive that the kiosk vending concept will not only work, but will be a blockbuster for Coinstar.
Brilliance Lost — Thursday’s IP Market Recap
September retail sales were up, helping Target, J.C. Penney and others, but Thursday’s headlines mostly rested on the loss of Apple’s Steve Jobs.
Dow Delights on Election Day — Tuesday’s IP Market Recap
Hewlett-Packard and Boeing helped lead the Dow to strong gains Tuesday, while the other major indices mostly followed suit.
Pharma Firms Duke It Out — Monday’s IP Market Recap
Pharmasset (VRUS) and Inhibitex (INHX) jump on positive hepatitis C drug news, and Vertex (VRTX) stock gets knocked back.
Analysts Run the Apple Asylum — Tuesday’s IP Market Recap
Price targets keep climbing to the moon: $715, $910 — even $1,001.
Boeing, 787 Dreamliner Flying High — Wednesday’s IP Market Recap
Boeing (BA) has a doubly good day, posting successful Q3 earnings and celebrating a successful 787 Dreamliner launch. Meanwhile, Amazon (AMZN) got hit as expected.
Pfizer’s Latest Gambit for Keeping Lipitor Alive
Like a vampire refusing to die, Lipitor keeps on going. Now, PFE has a deal to sell the cholesterol-lowering drug directly to patients at generic…
Stock Your Portfolio With Walgreen, Not CVS
Both CVS and Walgreen are fairly valued, but one stock is a more attractive investment. The winner is …
Campaign to Kill Medco-Express Scripts Deal Likely Futile
It’s not very likely that major pharmaceuticals will be able to prevent Express Scripts from acquiring Medco. But they do have good reason to try.
In Case You Missed Tuesday
Stocks actually take a step backward on Tuesday.
Strong UnitedHealth Group Inc Earnings Keep Rally Going
UnitedHealth beat expectations once again with its Q4 report. And with the quarter showing a business operating on all cylinders, more upside is ahead.
Anthem Inc (ANTM), CVS Health Corp (CVS) Team Up in Prescription Drugs Deal
Anthem (ANTM) and CVS Health (CVS) have announced that they are teaming up to create a new pharmacy benefits manager in 2020.
41 Last-Minute Trades Before New Year’s
Christmas is upon us, and the New Year is drawing closer; here are some moves you can make in these 48 stocks before ringing in…
Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?
CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn’t announced. So far, WAG is…
Sides Form on Medco-Express Scripts Deal
With the Federal Trade Commission likely to give the deal a close eye, analysts and investors sound off varying degrees of optimism and pessimism about…
UnitedHealth Group Scores with Catamaran Buy (UNH) (CTRX)
UnitedHealth Group’s acquisition of Catamaran is a no-brainer and should only serve to drive more upside in UNH stock.
6 – 10 of 240 results
